Answers are grounded in this paper and cite their sources.
Analyzes inflammation-driven biomarkers for prostate cancer diagnosis in at-risk populations, suggesting new therapeutic approaches.
NF-κB and its downstream cytokines, IL-18 and IL-10, may serve as inflammation-driven, noninvasive biomarkers for prostate cancer diagnosis, staging, and risk stratification, particularly in populations exposed to environmental factors.
No takes yet. Share an insight, caveat, or question.
Dwivedi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: